Related Experiment Video
Updated: Jan 25, 2026

A Pathway Association Study Tool for GWAS Analyses of Metabolic Pathway Information
Published on: July 1, 2020
Pharmacogenomics in dermatology: tools for understanding gene-drug associations
Roxana Daneshjou1, Rachel Huddart2, Teri E Klein2,3
1Department of Dermatology, Stanford School of Medicine, Redwood City, California. roxanad@stanford.edu.
Abstract:
Pharmacogenomics aims to associate human genetic variability with differences in drug phenotypes in order to tailor drug treatment to individual patients. The massive amount of genetic data generated from large cohorts of patients with variable drug phenotypes have led to advances in this field. Understanding the application of pharmacogenomics in dermatology could inform clinical practice and provide insight for future research. The Pharmacogenomics Knowledge Base and the Clinical Pharmacogenetics Implementation Consortium are among the resources to help clinicians and researchers navigate the many gene-drug associations that have already been discovered. The implementation of clinical pharmacogenomics within health care systems remains an area of ongoing development. This review provides an introduction to the field of pharmacogenomics and to current pharmacogenomics resources using examples of gene-drug associations relevant to the field of dermatology.
Related Concept Videos
Understanding the Self
Understanding Memory
Understanding Love
Understanding Consciousness
Sleep, a crucial state, is characterized by reduced...
Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
Understanding Self-Concept

